C. Cooper

First name
C.
Last name
Cooper
Khalid, S., Calderon-Larranaga, S., Sami, A., Hawley, S., Judge, A., Arden, N., et al. (2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1
van Staa, T. P., Abenhaim, L., & Cooper, C. (1998). Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol.
Van Staa, T., Abenhaim, L., & Cooper, C. (1997). Upper gastrointestinal adverse events and cyclical etidronate. Am J Med.
van Staa, T. P., Leufkens, H., Abenhaim, L., & Cooper, C. (1998). Postmarketing surveillance of the safety of cyclic etidronate. Pharmacotherapy.
van Staa, T. P., Leufkens, H. G., Abenhaim, L., Zhang, B., & Cooper, C. (2000). Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford).
van Staa, T. P., Abenhaim, L., Cooper, C., Zhang, B., & Leufkens, H. G. (2000). The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-e
van Staa, T. P., Leufkens, H. G., & Cooper, C. (2000). Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone.
van Staa, T. P., Leufkens, H. G., Abenhaim, L., Zhang, B., & Cooper, C. (2000). Use of oral corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2000.15.6.993
van Staa, T. P., Leufkens, H. G., Abenhaim, L., Begaud, B., Zhang, B., & Cooper, C. (2000). Use of oral corticosteroids in the United Kingdom. Qjm.
van Staa, T. P., Abenhaim, L., Cooper, C., Zhang, B., & Leufkens, H. G. (2001). Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol.